Bouge
Bouge
Bouge, Belgium6 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Treatment With Bempedoic Acid and/or Its Fixed-dose Combination With Ezetimibe in Primary Hypercholesterolemia or Mixed Dyslipidemia | Dyslipidemias, Hypercholesterolemia, Lipid Metabolism Disorders, Nutritional and Metabolic Diseases, hyperlipidemia, metabolic disease | Active, not recruiting | Not stated | 2026-09-30 | NCT04579367 | |
| Observational Real-life Study of Cabozantinib in Monotherapy or in Combination With Nivolumab in Advanced Renal Cell Carcinoma (RCC) | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, adenocarcinoma, benign urinary system neoplasm, carcinoma, epithelial neoplasm, kidney cancer, kidney disorder, neoplasm, renal cell carcinoma, urinary system disorder | Active, not recruiting | Not stated | 2026-09-30 | NCT04106349 | |
| Randomized, Placebo-controlled, Double Blind Study to Evaluate the Efficacy of 2LVERU®JUNIOR and 2LVERU® on the Treatment of Warts | DNA Virus Infections, Infections, Skin Diseases, Viral, Skin and Connective Tissue Diseases, Tumor Virus Infections, common wart, human papilloma virus infection, plantar wart, skin disorder, skin disorder caused by infection, viral infectious disease | Recruiting | Phase 4 | 2026-08-31 | NCT03977753 | |
| Randomized, Placebo-controlled, Double-blind Study of 2LHERP® in Orofacial Herpes Infections. | DNA Virus Infections, Herpesviridae infectious disease, Infections, Skin Diseases, Viral, Skin and Connective Tissue Diseases, herpes simplex infectious disease, skin disorder, skin disorder caused by infection, viral infectious disease | Recruiting | Phase 4 | 2026-08-27 | NCT04065971 | |
| Impact of Preoperative FFR on Arterial Bypass Graft Functionality | cardiovascular disorder, heart disorder | Active, not recruiting | Not applicable | 2026-05-01 | NCT02527044 | |
| ASPIRIN Trial Belgium | Digestive System Diseases, Digestive System Neoplasms, Disease Attributes, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, colonic disorder, colonic neoplasm, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, malignant colon neoplasm, neoplasm, rectal disorder | Active, not recruiting | Phase 3 | 2024-03-19 | NCT03464305 |